Onset and period are only a function of the toxin's molecular potency to the point of overall saturation of NMJs. Any variety of BoNT?A molecules earlier The purpose of saturation will then be unbound and clinically ineffective. Greater molecular potency may well raise the volume of adverse activities (AEs), but this is often dependent upon the str